Nripesh Sadasukhi

1PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 09, 2024
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Jiten Jaipuria, Ankita Jain, Shashikant Gupta

Pageof 1

Frequent Collaborators

1 joint publications

Jiten Jaipuria

1 joint publications

Ankita Jain

1 joint publications

Shashikant Gupta

1 joint publications

Priyatham Kasaraneni